Modeling the economic and epidemiologic impact of hookworm vaccine and mass drug administration (MDA) in Brazil, a high transmission setting

Vaccine

Volumn 34, Issue 19, 2016, Pages 2197-2206

  Bartsch, Sarah M ^a   Hotez, Peter J ^b,c   Hertenstein, Daniel L ^a   Diemert, David J ^c,d   Zapf, Kristina M ^a   Bottazzi, Maria Elena ^b,c   Bethony, Jeffrey M ^c,d   Brown, Shawn T ^e   Lee, Bruce Y ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c SABIN VACCINE INSTITUTE   (United States)

^d GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^e CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

Cost; Drug treatment; Economics; Hookworm; Transmission; Vaccine

Indexed keywords

HOOKWORM VACCINE; UNCLASSIFIED DRUG; VACCINE; ANTHELMINTIC AGENT;

ARTICLE; BRAZIL; COMPARTMENT MODEL; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; DRUG EFFICACY; EPIDEMIC; HEALTH ECONOMICS; HOOKWORM; HOOKWORM INFECTION; MASS IMMUNIZATION; PREVALENCE; PRIORITY JOURNAL; TREATMENT OUTCOME; ADOLESCENT; CHILD; COST BENEFIT ANALYSIS; ECONOMIC MODEL; ECONOMICS; HOOKWORM INFECTIONS; HUMAN; INFANT; NEWBORN; PRESCHOOL CHILD;

ADOLESCENT; ANTHELMINTICS; BRAZIL; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; HOOKWORM INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MASS VACCINATION; MODELS, ECONOMIC; VACCINES;

EID: 84962592135     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.03.018     Document Type: Article

References (75)

1. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015, 386:743-800. Global Burden of Disease Study 2013 Collaborators.
2. Smith J.L., Brooker S. Impact of hookworm infection and deworming on anaemia in non-pregnant populations: a systematic review. Trop Med Int Health 2010, 15:776-795.
3. Adegnika A.A., Zinsou J.F., Issifou S., Ateba-Ngoa U., Kassa R.F., Feugap E.N., et al. Randomized, controlled, assessor-blind clinical trial to assess the efficacy of single-versus repeated-dose albendazole to treat ascaris lumbricoides, trichuris trichiura, and hookworm infection. Antimicrob Agents Chemother 2014, 58:2535-2540.
4. Soukhathammavong P.A., Sayasone S., Phongluxa K., Xayaseng V., Utzinger J., Vounatsou P., et al. Low efficacy of single-dose albendazole and mebendazole against hookworm and effect on concomitant helminth infection in Lao PDR. PLoS Negl Trop Dis 2012, 6:e1417.
5. Hotez P.J., Bethony J.M., Oliveira S.C., Brindley P.J., Loukas A. Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis. Expert Rev Vaccines 2008, 7:745-752.
6. Chesnaye N., Sinuon M., Socheat D., Koporc K., Mathieu E. Treatment coverage survey after a school-based mass distribution of mebendazole: Kampot Province, Cambodia. Acta Trop 2011, 118:21-26.
7. Kabatereine N.B., Brooker S., Koukounari A., Kazibwe F., Tukahebwa E.M., Fleming F.M., et al. Impact of a national helminth control programme on infection and morbidity in Ugandan schoolchildren. Bull World Health Organ 2007, 85:91-99.
8. Guyatt H.L., Brooker S., Kihamia C.M., Hall A., Bundy D.A. Evaluation of efficacy of school-based anthelmintic treatments against anaemia in children in the United Republic of Tanzania. Bull World Health Organ 2001, 79:695-703.
9. Planning, requesting medicines and reporting for preventive chemotherapy. Wkly Epidemiol Rec 2015, 90:133-148. World Health Organization.
10. Hotez P.J., Brindley P.J., Bethony J.M., King C.H., Pearce E.J., Jacobson J. Helminth infections: the great neglected tropical diseases. J Clin Invest 2008, 118:1311-1321.
11. Knopp S., Mohammed K.A., Rollinson D., Stothard J.R., Khamis I.S., Utzinger J., et al. Changing patterns of soil-transmitted helminthiases in Zanzibar in the context of national helminth control programs. Am J Trop Med Hyg 2009, 81:1071-1078.
12. Cundill B., Alexander N., Bethony J.M., Diemert D., Pullan R.L., Brooker S. Rates and intensity of re-infection with human helminths after treatment and the influence of individual, household, and environmental factors in a Brazilian community. Parasitology 2011, 138:1406-1416.
13. Albonico M., Smith P.G., Ercole E., Hall A., Chwaya H.M., Alawi K.S., et al. Rate of reinfection with intestinal nematodes after treatment of children with mebendazole or albendazole in a highly endemic area. Trans R Soc Trop Med Hyg 1995, 89:538-541.
14. Lo N.C., Bogoch I.I., Blackburn B.G., Raso G., N'Goran E.K., Coulibaly J.T., et al. Comparison of community-wide, integrated mass drug administration strategies for schistosomiasis and soil-transmitted helminthiasis: a cost-effectiveness modelling study. Lancet Glob Health 2015, 3:e629-e638.
15. Anderson R.M., Turner H.C., Truscott J.E., Hollingsworth T.D., Brooker S.J. Should the goal for the treatment of Soil Transmitted Helminth (STH) infections be changed from morbidity control in children to community-wide transmission elimination?. PLoS Negl Trop Dis 2015, 9:e0003897.
16. Keiser J., Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. JAMA 2008, 299:1937-1948.
17. De Clercq D., Sacko M., Behnke J., Gilbert F., Dorny P., Vercruysse J. Failure of mebendazole in treatment of human hookworm infections in the southern region of Mali. Am J Trop Med Hyg 1997, 57:25-30.
18. Albonico M., Bickle Q., Ramsan M., Montresor A., Savioli L., Taylor M. Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar. Bull World Health Organ 2003, 81:343-352.
19. Hotez P.J., Bethony J.M., Diemert D.J., Pearson M., Loukas A. Developing vaccines to combat hookworm infection and intestinal schistosomiasis. Nat Rev Microbiol 2010, 8:814-826.
20. Bethony J., Brooker S., Albonico M., Geiger S.M., Loukas A., Diemert D., et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 2006, 367:1521-1532.
21. Anderson R., Truscott J., Hollingsworth T.D. The coverage and frequency of mass drug administration required to eliminate persistent transmission of soil-transmitted helminths. Philos Trans R Soc Lond B Biol Sci 2014, 369:20130435.
22. Anderson R.M., Truscott J.E., Pullan R.L., Brooker S.J., Hollingsworth T.D. How effective is school-based deworming for the community-wide control of soil-transmitted helminths?. PLoS Negl Trop Dis 2013, 7:e2027.
23. Chan M.S., Guyatt H.L., Bundy D.A., Medley G.F. The development and validation of an age-structured model for the evaluation of disease control strategies for intestinal helminths. Parasitology 1994, 109(Pt 3):389-396.
24. Truscott J., Hollingsworth T.D., Anderson R. Modeling the interruption of the transmission of soil-transmitted helminths by repeated mass chemotherapy of school-age children. PLoS Negl Trop Dis 2014, 8:e3323.
25. Chan M.S., Bradley M., Bundy D.A. Transmission patterns and the epidemiology of hookworm infection. Int J Epidemiol 1997, 26:1392-1400.
26. Sabatelli L., Ghani A.C., Rodrigues L.C., Hotez P.J., Brooker S. Modelling heterogeneity and the impact of chemotherapy and vaccination against human hookworm. J R Soc Interface 2008, 5:1329-1341.
27. Truscott J.E., Turner H.C., Anderson R.M. What impact will the achievement of the current World Health Organisation targets for anthelmintic treatment coverage in children have on the intensity of soil transmitted helminth infections?. Parasit Vectors 2015, 8:551.
28. Anderson R.M., May R.M. Population dynamics of human helminth infections: control by chemotherapy. Nature 1982, 297:557-563.
29. Schad G.A., Anderson R.M. Predisposition to hookworm infection in humans. Science 1985, 228:1537-1540.
30. Hotez P.J., Diemert D., Bacon K.M., Beaumier C., Bethony J.M., Bottazzi M.E., et al. The human hookworm vaccine. Vaccine 2013, 31(Suppl. 2):B227-B232.
31. Diemert D.J., Bethony J.M., Hotez P.J. Hookworm vaccines. Clin Infect Dis 2008, 46:282-288.
32. Boselli G., Yajima A., Aratchige P.E., Feldon K.E., Xeuatvongsa A., Phounphenghak K., et al. Integration of deworming into an existing immunisation and vitamin A supplementation campaign is a highly effective approach to maximise health benefits with minimal cost in Lao PDR. Int Health 2011, 3:240-245.
33. Brooker S., Kabatereine N.B., Fleming F., Devlin N. Cost and cost-effectiveness of nationwide school-based helminth control in Uganda: intra-country variation and effects of scaling-up. Health Policy Plan 2008, 23:24-35.
34. Fiedler J.L., Chuko T. The cost of child health days: a case study of Ethiopia's Enhanced Outreach Strategy (EOS). Health Policy Plan 2008, 23:222-233.
35. Goldman A.S., Brady M.A., Direny A., Desir L., Oscard R., Vely J.F., et al. Costs of integrated mass drug administration for neglected tropical diseases in Haiti. Am J Trop Med Hyg 2011, 85:826-833.
36. World Health Organization. PCT databank. Soil-transmitted helminthiases. Geneva, Switzerland: World Health Organization. http://www.who.int/neglected_diseases/preventive_chemotherapy/sth/en/.
37. The human hookworm vaccine 2015, Sabin Vaccine Institute. http://issuu.com/sabinvaccineinstitute/docs/hookworm_prospectus_101615.
38. Accelerating work to overcoming the global impact of neglected tropical disease. A roadmap for implementation 2012, World Health Organization, World Health Organization, Geneva, Switzerland.
39. Lee B.Y., Burke D.S. Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstacles. Vaccine 2010, 28:2806-2809.
40. Lee B.Y., McGlone S.M. Pricing of new vaccines. Hum Vaccines 2010, 6:619-626.
41. Greenland K., Dixon R., Khan S.A., Gunawardena K., Kihara J.H., Smith J.L., et al. The epidemiology of soil-transmitted helminths in Bihar State, India. PLoS Negl Trop Dis 2015, 9:e0003790.
42. Oluwole A.S., Ekpo U.F., Karagiannis-Voules D.A., Abe E.M., Olamiju F.O., Isiyaku S., et al. Bayesian geostatistical model-based estimates of soil-transmitted helminth infection in Nigeria, including annual deworming requirements. PLoS Negl Trop Dis 2015, 9:e0003740.
43. Forrer A., Vounatsou P., Sayasone S., Vonghachack Y., Bouakhasith D., Utzinger J., et al. Risk profiling of hookworm infection and intensity in southern Lao People's Democratic Republic using Bayesian models. PLoS Negl Trop Dis 2015, 9:e0003486.
44. Humphries D., Nguyen S., Boakye D., Wilson M., Cappello M. The promise and pitfalls of mass drug administration to control intestinal helminth infections. Curr Opin Infect Dis 2012, 25:584-589.
45. Hicks J.H., Kremer M., Miguel E. The case for mass treatment of intestinal helminths in endemic areas. PLoS Negl Trop Dis 2015, 9:e0004214.
46. Ahuja A., Baird S., Hicks J.H., Kremer M., Miguel E., Powers S. When should governments subsidize health? The case of mass deworming. World Bank Econ Rev 2015, 29:S9-S24.
47. Lee B.Y., Bartsch S.M., Gorham K.M. Economic and financial evaluation of neglected tropical diseases. Adv Parasitol 2015, 87:329-417.
48. Karagiannis-Voules D.A., Biedermann P., Ekpo U.F., Garba A., Langer E., Mathieu E., et al. Spatial and temporal distribution of soil-transmitted helminth infection in sub-Saharan Africa: a systematic review and geostatistical meta-analysis. Lancet Infect Dis 2015, 15:74-84.
49. Flohr C., Tuyen L.N., Lewis S., Minh T.T., Campbell J., Britton J., et al. Low efficacy of mebendazole against hookworm in Vietnam: two randomized controlled trials. Am J Trop Med Hyg 2007, 76:732-736.
50. Curti E., Seid C.A., Hudspeth E., Center L., Rezende W., Pollet J., et al. Optimization and revision of the production process of the Necator americanus glutathione S-transferase 1 (Na-GST-1), the lead hookworm vaccine recombinant protein candidate. Hum Vaccines Immunother 2014, 10:1914-1925.
51. Pearson M.S., Jariwala A.R., Abbenante G., Plieskatt J., Wilson D., Bottazzi M.E., et al. New tools for NTD vaccines: a case study of quality control assays for product development of the human hookworm vaccine Na-APR-1M74. Hum Vaccines Immunother 2015, 11:1251-1257.
52. Seid C.A., Curti E., Jones R.M., Hudspeth E., Rezende W., Pollet J., et al. Expression, purification, and characterization of the Necator americanus aspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine. Hum Vaccines Immunother 2015, 11:1474-1488.
53. Lee B.Y. Digital decision making: computer models and antibiotic prescribing in the twenty-first century. Clin Infect Dis 2008, 46:1139-1141.
54. Stoltzfus R.J., Chwaya H.M., Tielsch J.M., Schulze K.J., Albonico M., Savioli L. Epidemiology of iron deficiency anemia in Zanzibari schoolchildren: the importance of hookworms. Am J Clin Nutr 1997, 65:153-159.
55. Sakti H., Nokes C., Hertanto W.S., Hendratno S., Hall A., Bundy D.A.P., et al. Evidence for an association between hookworm infection and cognitive function in Indonesian school children. Trop Med Int Health 1999, 4:322-334.
56. Hotez P.J., Brooker S., Bethony J.M., Bottazzi M.E., Loukas A., Xiao S. Hookworm infection. New Engl J Med 2004, 351:799-807.
57. Jardim-Botelho A., Raff S., de Avila Rodrigues R., Hoffman H.J., Diemert D.J., Correa-Oliveira R., et al. Hookworm, Ascaris lumbricoides infection and polyparasitism associated with poor cognitive performance in Brazilian schoolchildren. Trop Med Int Health 2008, 13:994-1004.
58. Brooker S., Bethony J., Hotez P.J. Human hookworm infection in the 21st century. Adv Parasitol 2004, 58:197-288.
59. World population prospects: the 2012 revision, DVD edition 2013, United Nations, Department of Economic and Social Affairs, Population Division.
60. Fleming F., Brooker S., Geiger S.M., Caldas I.R., Correa-Oliveira R., Hotez P.J., et al. Synergistic associations between hookworm and other helminth species in a rural community in Brazil. Trop Med Int Health 2006, 11:56-64.
61. Loukas A., Prociv P. Immune responses in hookworm infections. Clin Microbiol Rev 2001, 14:689-703. table of contents.
62. Anderson R., May R. Infectious diseases of humans: dynamics of control 1991, Oxford University Press, Inc., Oxford, NY.
63. Brazil: statistics 2010, UNICEF. http://www.unicef.org/infobycountry/brazil_statistics.html.
64. Bradley M., Chandiwana S.K., Bundy D.A., Medley G.F. The epidemiology and population biology of Necator americanus infection in a rural community in Zimbabwe. Trans R Soc Trop Med Hyg 1992, 86:73-76.
65. Lwambo N.J.S., Bundy D.A., Medley G.F. A new approach to morbidity risk assessment in hookworm endemic communities. Epidemiol Infect 1992, 108:469-481.
66. Pritchard D.I., Quinnell R.J., Slater A.F., McKean P.G., Dale D.D., Raiko A., et al. Epidemiology and immunology of Necator americanus infection in a community in Papua New Guinea: humoral responses to excretory-secretory and cuticular collagen antigens. Parasitology 1990, 100(Pt 2):317-326.
67. Ye X.P., Wu Z.X., Sun F.H. The population biology and control of Necator americanus in a village community in south-eastern China. Ann Trop Med Parasitol 1994, 88:635-643.
68. Keiser J., Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. J Am Med Assoc 2008, 299:1937-1948.
69. The global burden of disease: 2004 update 2008, World Health Organization, World Health Organization, Geneva, Switzerland.
70. Salomon J.A., Vos T., Hogan D.R., Gagnon M., Naghavi M., Mokdad A., et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012, 380:2129-2143.
71. Brooker S., Jardim-Botelho A., Quinnell R.J., Geiger S.M., Caldas I.R., Fleming F., et al. Age-related changes in hookworm infection, anaemia and iron deficiency in an area of high Necator americanus hookworm transmission in south-eastern Brazil. Trans R Soc Trop Med Hyg 2007, 101:146-154.
72. Stoltzfus R.J., Dreyfuss M.L., Chwaya H.M., Albonico M. Hookworm control as a strategy to prevent iron deficiency. Nutr Rev 1997, 55:223-232.
73. Koukounari A., Estambale B.B., Njagi J.K., Cundill B., Ajanga A., Crudder C., et al. Relationships between anaemia and parasitic infections in Kenyan schoolchildren: a Bayesian hierarchical modelling approach. Int J Parasitol 2008, 38:1663-1671.
74. Ngui R., Lim Y.A.L., Kin L.C., Cheun C.S., Jaffar S. Association between anaemia, iron deficiency anaemia, neglected parasitici infections and socioeconomic factors in rural children of West Malaysia. PLoS Negl Trop Dis 2012, 6:e1550.
75. Stephenson L.S., Latham M.C., Kurz K.M., Kinoti S.N., Oduori M.L., Crompton D.W.T. Relationships of Shistosoma hematobium, hookworm and malarial infections and metrifonate treatment to hemoglobin level in Kenyan school children. Am J Trop Med Hyg 1985, 34:519-528.